Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) reported Q3 EPS of ($0.51), $0.25 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Virpax Pharmaceuticals, Inc. (VRPX) click here.